Circio ASA: New Preclinical Data Expected on 29 November - Redeye

On 29 November, Circio will hold an R&D webinar. In addition to a general corporate and strategy update, the latest pre-clinical data, including in vivo results, will be presented, which is important to the investment case. Redeye will participate in this webinar and provide an assessment of the new results in a research note after they have been made available.

Länk till analysen i sin helhet: https://www.redeye.se/research/963362/circio-asa-new-preclinical-data-expected-on-29-november?utm_source=finwire&utm_medium=RSS